LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 45 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,492,000 | -48.3% | 1,511,417 | +2.5% | 0.05% | -46.7% |
| Q3 2021 | $6,752,000 | +7.0% | 1,474,108 | +3.8% | 0.09% | -3.2% |
| Q2 2021 | $6,308,000 | -38.1% | 1,420,452 | +1.5% | 0.09% | -34.0% |
| Q1 2021 | $10,190,000 | -5.8% | 1,399,844 | -1.2% | 0.14% | -9.0% |
| Q4 2020 | $10,815,000 | +53.9% | 1,417,446 | +83.2% | 0.16% | +22.0% |
| Q3 2020 | $7,027,000 | +5.5% | 773,895 | -1.7% | 0.13% | +3.3% |
| Q2 2020 | $6,658,000 | +68.8% | 787,015 | -1.4% | 0.12% | +23.0% |
| Q1 2020 | $3,945,000 | -26.0% | 798,566 | +7.9% | 0.10% | -10.7% |
| Q4 2019 | $5,328,000 | -23.0% | 740,046 | +15.6% | 0.11% | -33.3% |
| Q3 2019 | $6,918,000 | -16.7% | 639,977 | +0.2% | 0.17% | -4.0% |
| Q2 2019 | $8,300,000 | +32.5% | 638,499 | +0.7% | 0.18% | +18.2% |
| Q1 2019 | $6,266,000 | +9.6% | 634,283 | +15.4% | 0.15% | +8.8% |
| Q4 2018 | $5,716,000 | – | 549,539 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,466,783 | $19,558,000 | 0.25% |
| HARBOR CAPITAL ADVISORS, INC. | 282,578 | $653,000 | 0.24% |
| Sio Capital Management, LLC | 182,630 | $422,000 | 0.13% |
| SAMLYN CAPITAL, LLC | 1,511,417 | $3,492,000 | 0.05% |
| Eversept Partners, LP | 291,101 | $672,443 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 320,273 | $740,000 | 0.02% |
| PURA VIDA INVESTMENTS, LLC | 230,121 | $532,000 | 0.02% |
| Independence Bank of Kentucky | 12,875 | $30,000 | 0.01% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $35,000 | 0.01% |
| Baker Brothers Advisors | 451,478 | $1,043,000 | 0.01% |